Agilent Technologies, Inc.'s (NYSE:A) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
$100 Invested In Agilent Technologies 20 Years Ago Would Be Worth This Much Today
Trending Industry Today: Sangamo Therapeutics Leads Losses Pre-Market In Gene Editing Stocks
Agilent Technologies (NYSE:A) Jumps 5.8% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Express News | Agilent Technologies Receives FDA Approval For MAGE-A4 IHC 1F9 PharmDx As Diagnostic Tool To Identify Synovial Sarcoma Patients Eligible For TECELRA TCR T-Cell Therapy
Express News | Agilent Receives FDA Approval for Mage-a4 Ihc 1F9 Pharmdx as a Diagnostic Tool for Use With Newly Approved Tcr T-Cell Therapy
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Insider Sale: President and CEO Padraig Mcdonnell Sells Shares of Agilent Technologies Inc (A)
What to Expect From Agilent Technologies' Q3 2024 Earnings Report
Agilent Technologies Insider Sold Shares Worth $274,120, According to a Recent SEC Filing
Agilent Technologies, Inc.'s (NYSE:A) Shareholders Might Be Looking For Exit
Express News | Agilent Technologies Acquires Sigsense Technologies To Optimize Lab Operations Using AI And Power Monitoring; Financial Terms Not Disclosed
Express News | Agilent Technologies Inc: Financial Terms of Acquisition Were Not Disclosed.
Express News | Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology
Possible Bearish Signals With Agilent Technologies Insiders Disposing Stock
Agilent Technologies, Inc. (A): Hedge Funds Are Bullish on This Scientific Instruments Stock Now
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets to 2029 Featuring Profiles of Agilent Technologies, Roche, Illumina, Qiagen, and Thermo Fisher Scientific
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,500 Today
Estimating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
TD Cowen Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $153